Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clotilde Bravetti

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Journal of Cellular and Molecular Medicine|May 23, 2025
Phenotypic Profile of Waldenström Macroglobulinaemia B-Cells: Establishment of a Diagnosis Scoring System and Clinico-Biological CorrelationsElise Sourdeau, Clémentine Boccon-Gibod, Aurélien Corneau, et al.
Haematologica|July 14, 2022
Inflammation in Waldenström macroglobulinemia is associated with 6q deletion and need for treatment initiationNathalie Forgeard, Marine Baron, Jonathan Caron, et al.
BMC Biology|March 9, 2022
Hematopoietic differentiation is characterized by a transient peak of entropy at a single-cell levelCharles Dussiau, Agathe Boussaroque, Mathilde Gaillard, et al.
American Journal of Hematology|August 31, 2021
Cytogenetic and molecular abnormalities in Waldenström's macroglobulinemia patients: Correlations and prognostic impactDaphné Krzisch, Nayara Guedes, Clémentine Boccon-Gibod, et al.
Leukemia|September 26, 2023
del(8p) and TNFRSF10B loss are associated with a poor prognosis and resistance to fludarabine in chronic lymphocytic leukemiaLudovic Jondreville, Lea Dehgane, Cecile Doualle, et al.
Haematologica|June 11, 2026
Clonal expansion of CAR-T cells harboring lentivector integration in the PLAAT4 gene following anti-CD19 CAR T-cell therapy in a context of cutaneous T-cell lymphomaVincent Guiraud, Clotilde Bravetti, Amélie Guihot, et al.
British Journal of Haematology|March 21, 2023
Combining MYD88 L265P mutation detection and clonality determination on CSF cellular and cell-free DNA improves diagnosis of primary CNS lymphomaClotilde Bravetti, Michaël Degaud, Marine Armand, et al.
Leukemia|February 9, 2024
Circulating tumor cells in Waldenström macroglobulinemiaClémentine Boccon-Gibod, Elise Sourdeau, Pierre Morel, et al.
Haematologica|August 16, 2023
Inflammation is predictive of outcome in Waldenström macroglobulinemia treated by Bruton tyrosine kinase inhibitors: a multicentric real-life studyPierre-Edouard Debureaux, Nathalie Forgeard, Dikelele Elessa, et al.
Leukemia|December 9, 2025
REL overexpression and sustained NF-κB signaling associated with 2p gain induce resistance to BTK inhibitors in Chronic Lymphocytic LeukemiaLéa Dehgane, Eliane Mallet, Constance Brasseur, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Journal of Cellular and Molecular Medicine|May 23, 2025
Phenotypic Profile of Waldenström Macroglobulinaemia B-Cells: Establishment of a Diagnosis Scoring System and Clinico-Biological CorrelationsElise Sourdeau, Clémentine Boccon-Gibod, Aurélien Corneau, et al.
Haematologica|July 14, 2022
Inflammation in Waldenström macroglobulinemia is associated with 6q deletion and need for treatment initiationNathalie Forgeard, Marine Baron, Jonathan Caron, et al.
BMC Biology|March 9, 2022
Hematopoietic differentiation is characterized by a transient peak of entropy at a single-cell levelCharles Dussiau, Agathe Boussaroque, Mathilde Gaillard, et al.
American Journal of Hematology|August 31, 2021
Cytogenetic and molecular abnormalities in Waldenström's macroglobulinemia patients: Correlations and prognostic impactDaphné Krzisch, Nayara Guedes, Clémentine Boccon-Gibod, et al.
Leukemia|September 26, 2023
del(8p) and TNFRSF10B loss are associated with a poor prognosis and resistance to fludarabine in chronic lymphocytic leukemiaLudovic Jondreville, Lea Dehgane, Cecile Doualle, et al.
Haematologica|June 11, 2026
Clonal expansion of CAR-T cells harboring lentivector integration in the PLAAT4 gene following anti-CD19 CAR T-cell therapy in a context of cutaneous T-cell lymphomaVincent Guiraud, Clotilde Bravetti, Amélie Guihot, et al.
British Journal of Haematology|March 21, 2023
Combining MYD88 L265P mutation detection and clonality determination on CSF cellular and cell-free DNA improves diagnosis of primary CNS lymphomaClotilde Bravetti, Michaël Degaud, Marine Armand, et al.
Leukemia|February 9, 2024
Circulating tumor cells in Waldenström macroglobulinemiaClémentine Boccon-Gibod, Elise Sourdeau, Pierre Morel, et al.
Haematologica|August 16, 2023
Inflammation is predictive of outcome in Waldenström macroglobulinemia treated by Bruton tyrosine kinase inhibitors: a multicentric real-life studyPierre-Edouard Debureaux, Nathalie Forgeard, Dikelele Elessa, et al.
Leukemia|December 9, 2025
REL overexpression and sustained NF-κB signaling associated with 2p gain induce resistance to BTK inhibitors in Chronic Lymphocytic LeukemiaLéa Dehgane, Eliane Mallet, Constance Brasseur, et al.
Pageof 3